DARA Share Price |
||||
| Open | 0.00 | Change | Price | % |
| High | 0.95 | 1 Day | 0.00 | 0.00 |
| Low | 0.88 | 1 Week | 0.00 | 0.00 |
| Close | 0.88 | 1 Month | 0.00 | 0.00 |
| Volume | 391218 | 1 Year | 0.00 | 0.00 |
| 52 Week High 11.12 | ||||
| 52 Week Low 7.84 | ||||
| DARA Important Levels | |
| Resistance 2 | 0.94 |
| Resistance 1 | 0.92 |
| Pivot | 0.90 |
| Support 1 | 0.84 |
| Support 2 | 0.82 |
| NASDAQ USA Most Active Stocks | |||
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| FNFG | 10.18 | -0.20% | |
| DELL | 13.86 | 0.22% | |
| RFMD | 16.59 | -2.07% | |
| MU | 44.31 | 6.39% | |
| MU | 44.31 | 6.39% | |
| MU | 44.31 | 6.39% | |
| RIMM | 13.03 | 0.39% | |
| NASDAQ USA Top Gainers Stocks | |||
| LOCM | 0.09 | 50.00% | |
| SCHS | 0.04 | 33.33% | |
| BSDM | 0.62 | 26.53% | |
| SNTA | 0.34 | 25.93% | |
| HLIT | 3.70 | 25.42% | |
| OTT | 2.39 | 25.13% | |
| QNST | 8.90 | 20.76% | |
| VRTA | 4.00 | 19.40% | |
| SNSS | 2.56 | 19.07% | |
| GCFB | 0.44 | 18.92% | |
| NASDAQ USA Top Losers Stocks | |||
| TXCC | 0.01 | -95.00% | |
| GMETP | 0.15 | -76.92% | |
| HCIIP | 10.10 | -67.52% | |
| CRMB | 0.27 | -57.81% | |
| KIOR | 0.03 | -57.14% | |
| OSH | 0.26 | -49.02% | |
| OSH | 0.26 | -49.02% | |
| DVOX | 0.05 | -44.44% | |
| PRXI | 0.21 | -43.24% | |
| TRGT | 0.96 | -41.46% | |
DARA Biosciences, Inc. (NASDAQ: DARA)
| DARA Technical Analysis | 3 |
| As on 4th Dec 2015 DARA Share Price closed @ 0.88 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.85 & Buy for SHORT-TERM with Stoploss of 0.86 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| DARA Target for June | |
| 1st Target up-side | N/A |
| 2nd Target up-side | N/A |
| 3rd Target up-side | N/A |
| 1st Target down-side | N/A |
| 2nd Target down-side | N/A |
| 3rd Target down-side | N/A |
DARA Biosciences, Inc. ( NASDAQ USA Symbol : DARA ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
ABAX
48.40 0.54 (1.13 %) LT : Sell ST : Buy |
ABIO
1.21 0.01 (0.83 %) LT : Strong Sell ST : Sell |
ABMD
192.92 13.44 (7.49 %) LT : Strong Buy ST : Strong Buy |
ACAD
34.83 -0.35 (-0.99 %) LT : Buy ST : Sell |
ACHC
31.36 0.03 (0.10 %) LT : Strong Sell ST : Strong Sell |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart DARA Biosciences, Inc. ( DARA NASDAQ USA )
Your Comments and Response on DARA Biosciences, Inc.
DARA Business Profile
DARA BioSciences, Inc. is a specialty pharmaceutical company primarily focused on the commercialization of oncology treatment and oncology supportive care pharmaceutical products. The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy (CCIPN). Its primary focus is on the commercialization of the oncology treatment and oncology supportive care pharmaceutical products, which include Soltamox, Cancer support therapeutics and Three Mission Pharmacal products. The Company�s oral liquid products can provide a alternative to solid dose formulations for those patients with dysphagia, or difficulty swallowing, or those who simply prefer to take drug products in liquid form.